Why These 5 Stocks Are on the Move on Friday

2. Moderna, Inc. (NASDAQ:MRNA) has fallen 12% due to the Merck news, which could potentially shorten the pandemic. Moderna, Inc. (NASDAQ:MRNA) will need to continue to innovate for its stock to do well after the pandemic. Stephen Mandel‘s Lone Pine Capital was long almost 4 million shares of Moderna, Inc. (NASDAQ:MRNA) at the end of June.